Multiple potential regulatory sites of TLR4 activation induced by LPS as revealed by novel inhibitory human TLR4 mAbs

International Immunology

Volumn 24, Issue 8, 2012, Pages 495-506

  Tsukamoto, Hiroki ^a,b   Fukudome, Kenji ^a   Takao, Shoko ^a   Tsuneyoshi, Naoko ^a   Ihara, Hideyuki ^b   Ikeda, Yoshitaka ^b   Kimoto, Masao ^a  

^a SAGA UNIVERSITY   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Inhibitory mAb; Innate immunity; MD 2; Toll like receptor 4

Indexed keywords

CD32 ANTIGEN; CD86 ANTIGEN; EPITOPE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HT4; MONOCLONAL ANTIBODY HT52; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANTIBODY COMBINING SITE; ARTICLE; BIOCHEMISTRY; CELL STRAIN HEK293; CYTOKINE PRODUCTION; DELETION MUTANT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; INNATE IMMUNITY; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL LINE; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNITY, INNATE; IMMUNOPRECIPITATION; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

EID: 84865088376     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs053     Document Type: Article

References (28)

1. Akira, S., Uematsu, S. and Takeuchi, O. 2006. Pathogen recognition and innate immunity. Cell 124:783.
2. Hennessy, E. J., Parker, A. E. and O'Neill, L. A. 2010. Targeting Toll-like receptors: emerging therapeutics? Nat. Rev. Drug Discov. 9:293.
3. Hoshino, K., Takeuchi, O., Kawai, T. et al. 1999. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749.
4. Liu, B., Yang, Y., Dai, J. et al. 2006. TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease. J. Immunol. 177:6880.
5. Lartigue, A., Colliou, N., Calbo, S. et al. 2009. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J. Immunol. 183:6207.
6. Choe, J. Y., Crain, B., Wu, S. R. and Corr, M. 2003. Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J. Exp. Med. 197:537.
7. Kang, J. Y. and Lee, J. O. 2011. Structural biology of the toll-like receptor family. Annu. Rev. Biochem. 80:917.
8. Nagai, Y., Akashi, S., Nagafuku, M. et al. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3:667.
9. Kim, H. M., Park, B. S., Kim, J. I. et al. 2007. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130:906.
10. Park, B. S., Song, D. H., Kim, H. M., Choi, B. S., Lee, H. and Lee, J. O. 2009. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:1191.
11. da Silva Correia, J. and Ulevitch, R. J. 2002. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J. Biol. Chem. 277:1845.
12. Fujimoto, T., Yamazaki, S., Eto-Kimura, A., Takeshige, K. and Muta, T. 2004. The amino-terminal region of toll-like receptor 4 is essential for binding to MD-2 and receptor translocation to the cell surface. J. Biol. Chem. 279:47431.
13. Resman, N., Vasl, J., Oblak, A. et al. 2009. Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin. J. Biol. Chem. 284:15052.
14. Meng, J., Lien, E. and Golenbock, D. T. 2010. MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation. J. Biol. Chem. 285:8695.
15. Nishitani, C., Mitsuzawa, H., Sano, H., Shimizu, T., Matsushima, N. and Kuroki, Y. 2006. Toll-like receptor 4 region Glu24-Lys47 is a site for MD-2 binding: importance of CYS29 and CYS40. J. Biol. Chem. 281:38322.
16. Tsuneyoshi, N., Fukudome, K., Kohara, J. et al. 2005. The functional and structural properties of MD-2 required for lipopolysaccharide binding are absent in MD-1. J. Immunol. 174:340.
17. Mullarkey, M., Rose, J. R., Bristol, J. et al. 2003. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J. Pharmacol. Exp. Ther. 304:1093.
18. Christ, W. J., Asano, O., Robidoux, A. L. et al. 1995. E5531, a pure endotoxin antagonist of high potency. Science 268:80.
19. Kovach, N. L., Yee, E., Munford, R. S., Raetz, C. R. and Harlan, J. M. 1990. Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J. Exp. Med. 172:77.
20. Akashi, S., Ogata, H., Kirikae, F. et al. 2000. Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. Biochem. Biophys. Res. Commun. 268:172.
21. Dunn-Siegrist, I., Leger, O., Daubeuf, B. et al. 2007. Pivotal involvement of Fcc receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1. J. Biol. Chem. 282:34817.
22. Tsuneyoshi, N., Kohara, J., Bahrun, U. et al. 2006. Penta-acylated lipopolisaccharide binds to murine MD-2 but does not induce the oligomerization of TLR4 required for signal transduction. Cell. Immunol. 244:57.
23. Bahrun, U., Kimoto, M., Tsukamoto, H., Tsuneyoshi, N., Kohara, J. and Fukudome, K. 2007. Preparation and characterization of agonistic monoclonal antibodies against Toll-like receptor 4-MD-2 complex. Hybridoma (Larchmt) 26:393.
24. Tsukamoto, H., Fukudome, K., Takao, S., Tsuneyoshi, N. and Kimoto, M. 2010. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. Int. Immunol. 22:271.
25. Park, S. J., Kang, S. H., Kang, Y. K. et al. 2011. Inhibition of homodimerization of toll-like receptor 4 by 4-oxo-4-(2-oxo-oxazolidin- 3-yl)-but-2-enoic acid ethyl ester. Int. Immunopharmacol. 11:19.
26. Youn, H. S., Saitoh, S. I., Miyake, K. and Hwang, D. H. 2006. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem. Pharmacol. 72:62.
27. Zanoni, I., Ostuni, R., Marek, L. R. et al. 2011. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147:868.
28. Kagan, J. C., Su, T., Horng, T., Chow, A., Akira, S. and Medzhitov, R. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 3 9:361.